Annual Shareholders Equity
$1.13 B
-$2.87 M-0.25%
December 31, 2024
Summary
- As of March 12, 2025, FLGT annual stockholders equity is $1.13 billion, with the most recent change of -$2.87 million (-0.25%) on December 31, 2024.
- During the last 3 years, FLGT annual shareholders equity has fallen by -$25.52 million (-2.20%).
- FLGT annual shareholders equity is now -10.54% below its all-time high of $1.27 billion, reached on December 31, 2022.
Performance
FLGT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.13 B
-$5.22 M-0.46%
December 31, 2024
Summary
- As of March 12, 2025, FLGT quarterly stockholders equity is $1.13 billion, with the most recent change of -$5.22 million (-0.46%) on December 31, 2024.
- Over the past year, FLGT quarterly shareholders equity has stayed the same.
- FLGT quarterly shareholders equity is now -13.24% below its all-time high of $1.31 billion, reached on March 31, 2022.
Performance
FLGT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
FLGT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.3% | 0.0% |
| 3 y3 years | -2.2% | 0.0% |
| 5 y5 years | +1269.0% | +1269.0% |
FLGT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.5% | at low | -13.2% | +0.3% |
| 5 y | 5-year | -10.5% | +1269.0% | -13.2% | +1292.7% |
| alltime | all time | -10.5% | >+9999.0% | -13.2% | >+9999.0% |
Fulgent Genetics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.13 B(-0.3%) | $1.13 B(-0.5%) |
| Sep 2024 | - | $1.14 B(+0.5%) |
| Jun 2024 | - | $1.13 B(+0.2%) |
| Mar 2024 | - | $1.13 B(-0.5%) |
| Dec 2023 | $1.14 B(-10.3%) | $1.14 B(-9.7%) |
| Sep 2023 | - | $1.26 B(-0.1%) |
| Jun 2023 | - | $1.26 B(-0.4%) |
| Mar 2023 | - | $1.26 B(-0.2%) |
| Dec 2022 | $1.27 B(+9.3%) | $1.27 B(-0.8%) |
| Sep 2022 | - | $1.28 B(-2.1%) |
| Jun 2022 | - | $1.30 B(-0.1%) |
| Mar 2022 | - | $1.31 B(+12.7%) |
| Dec 2021 | $1.16 B(+103.5%) | $1.16 B(+11.8%) |
| Sep 2021 | - | $1.04 B(+13.6%) |
| Jun 2021 | - | $912.73 M(+13.9%) |
| Mar 2021 | - | $801.57 M(+40.8%) |
| Dec 2020 | $569.39 M | $569.39 M(+204.6%) |
| Sep 2020 | - | $186.96 M(+114.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $87.04 M(+7.0%) |
| Mar 2020 | - | $81.37 M(-1.7%) |
| Dec 2019 | $82.78 M(+61.8%) | $82.78 M(+51.8%) |
| Sep 2019 | - | $54.53 M(+6.6%) |
| Jun 2019 | - | $51.14 M(+2.4%) |
| Mar 2019 | - | $49.96 M(-2.3%) |
| Dec 2018 | $51.15 M(-5.6%) | $51.15 M(-2.7%) |
| Sep 2018 | - | $52.58 M(+0.0%) |
| Jun 2018 | - | $52.56 M(-0.9%) |
| Mar 2018 | - | $53.02 M(-2.1%) |
| Dec 2017 | $54.18 M(-0.6%) | $54.18 M(-2.0%) |
| Sep 2017 | - | $55.27 M(-0.8%) |
| Jun 2017 | - | $55.73 M(+0.8%) |
| Mar 2017 | - | $55.30 M(+1.5%) |
| Dec 2016 | $54.48 M(+958.7%) | $54.48 M(+215.9%) |
| Sep 2016 | - | $17.25 M(-20.5%) |
| Jun 2016 | - | $21.70 M(+321.7%) |
| Dec 2015 | $5.15 M(+205.6%) | $5.15 M |
| Dec 2014 | $1.68 M | - |
FAQ
- What is Fulgent Genetics annual stockholders equity?
- What is the all time high annual shareholders equity for Fulgent Genetics?
- What is Fulgent Genetics annual shareholders equity year-on-year change?
- What is Fulgent Genetics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Fulgent Genetics?
- What is Fulgent Genetics quarterly shareholders equity year-on-year change?
What is Fulgent Genetics annual stockholders equity?
The current annual shareholders equity of FLGT is $1.13 B
What is the all time high annual shareholders equity for Fulgent Genetics?
Fulgent Genetics all-time high annual stockholders equity is $1.27 B
What is Fulgent Genetics annual shareholders equity year-on-year change?
Over the past year, FLGT annual stockholders equity has changed by -$2.87 M (-0.25%)
What is Fulgent Genetics quarterly stockholders equity?
The current quarterly shareholders equity of FLGT is $1.13 B
What is the all time high quarterly shareholders equity for Fulgent Genetics?
Fulgent Genetics all-time high quarterly stockholders equity is $1.31 B
What is Fulgent Genetics quarterly shareholders equity year-on-year change?
Over the past year, FLGT quarterly stockholders equity has changed by $0.00 (0.00%)